Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color

NCT: NCT05362929 · RECRUITING

NCT IDNCT05362929
StatusRECRUITING
Start Date2023-10-11
Completion2029-07
SponsorAlbert Einstein College of Medicine (OTHER)
First posted
Last updated

Brief Summary

The investigators aim to investigate the efficacy and tolerability of a hybrid non-ablative/ablative laser for acne scarring in skin of color.

Frequently Asked Questions

What is Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color?

Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color is a clinical trial registered under NCT05362929. Current status: RECRUITING.

What is the status of NCT05362929?

The current status of NCT05362929 (Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color) is: RECRUITING.

When did Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color start?

Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color started on 2023-10-11.

Related Devices

K192350Medical Non-Ablative Fractional Laser SystemsWingderm Electro-Optics , Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑